These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16378598)

  • 61. Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma.
    Qiao Q; Jiang Y; Li G
    J Pharmacol Sci; 2013; 121(4):247-56. PubMed ID: 23603894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the PI3-kinase/Akt pathway in cultured Ra2 microglial cells.
    Ito S; Sawada M; Haneda M; Fujii S; Oh-Hashi K; Kiuchi K; Takahashi M; Isobe K
    FEBS Lett; 2005 Mar; 579(9):1995-2000. PubMed ID: 15792809
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of cellular growth, apoptosis, and Akt activity in human U251 glioma cells by a combination of cisplatin with CRM197.
    Wang L; Wang P; Liu Y; Xue Y
    Anticancer Drugs; 2012 Jan; 23(1):81-9. PubMed ID: 21934602
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line.
    Jaiswal K; Tello V; Lopez-Guzman C; Nwariaku F; Anthony T; Sarosi GA
    Surgery; 2004 Aug; 136(2):160-8. PubMed ID: 15300175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selenium effectively inhibits 1,2-dihydroxynaphthalene-induced apoptosis in human lens epithelial cells through activation of PI3-K/Akt pathway.
    Zhu X; Guo K; Lu Y
    Mol Vis; 2011; 17():2019-27. PubMed ID: 21850177
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of the PI3K/Akt pathway by Ly294002 does not prevent establishment of persistent Junín virus infection in Vero cells.
    Linero FN; Fernández Bell-Fano PM; Cuervo E; Castilla V; Scolaro LA
    Arch Virol; 2015 Feb; 160(2):469-75. PubMed ID: 25488290
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair.
    Westhoff MA; Kandenwein JA; Karl S; Vellanki SH; Braun V; Eramo A; Antoniadis G; Debatin KM; Fulda S
    Oncogene; 2009 Oct; 28(40):3586-96. PubMed ID: 19633683
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nitidine chloride inhibits proliferation, induces apoptosis via the Akt pathway and exhibits a synergistic effect with doxorubicin in ovarian cancer cells.
    Ding F; Liu T; Yu N; Li S; Zhang X; Zheng G; Lv C; Mou K; Xu J; Li B; Wang S; Song H
    Mol Med Rep; 2016 Sep; 14(3):2853-9. PubMed ID: 27485415
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effects of combining tumor necrosis factor related apoptosis-inducing ligand with PI3-K-Akt inhibition on nasopharyngeal carcinoma cell].
    Li SS; Tang QL; Wang SH; Chen YH; Liu JJ; Wang S; Yang XM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):854-8. PubMed ID: 22321426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy.
    Long XH; Zhong ZH; Peng AF; Zhu LB; Wang H; Zhang GM; Liu ZL
    Mol Med Rep; 2014 Dec; 10(6):2967-72. PubMed ID: 25310590
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
    Fedier A; Erdmann R; Boulikas T; Fink D
    Int J Oncol; 2006 Nov; 29(5):1303-10. PubMed ID: 17016665
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway.
    Ueba H; Kuroki M; Hashimoto S; Umemoto T; Yasu T; Ishikawa SE; Saito M; Kawakami M
    Atherosclerosis; 2005 Nov; 183(1):35-9. PubMed ID: 16216590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Over-expression of COX-2 induces human ovarian cancer cells (CAOV-3) viability, migration and proliferation in association with PI3-k/Akt activation.
    Gu P; Su Y; Guo S; Teng L; Xu Y; Qi J; Gong H; Cai Y
    Cancer Invest; 2008 Oct; 26(8):822-9. PubMed ID: 18798061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1.
    Abdul-Ghani R; Serra V; Györffy B; Jürchott K; Solf A; Dietel M; Schäfer R
    Oncogene; 2006 Mar; 25(12):1743-52. PubMed ID: 16288223
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of tachykinin NK
    Bayati S; Bashash D; Ahmadian S; Safaroghli-Azar A; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2016 Nov; 791():274-283. PubMed ID: 27609608
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intracellular signal transduction pathways in the regulation of fowl sperm motility: evidence for the involvement of phosphatidylinositol 3-kinase (PI3-K) cascade.
    Ashizawa K; Omura Y; Katayama S; Tatemoto H; Narumi K; Tsuzuki Y
    Mol Reprod Dev; 2009 Jul; 76(7):603-10. PubMed ID: 19117024
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status.
    Buontempo F; Ersahin T; Missiroli S; Senturk S; Etro D; Ozturk M; Capitani S; Cetin-Atalay R; Neri ML
    Invest New Drugs; 2011 Dec; 29(6):1303-13. PubMed ID: 20628892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation.
    Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
    Exp Hematol; 2000 Nov; 28(11):1239-49. PubMed ID: 11063872
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells.
    Leśkiewicz M; Regulska M; Budziszewska B; Jantas D; Jaworska-Feil L; Basta-Kaim A; Kubera M; Lasoń W
    Pharmacol Rep; 2008; 60(5):685-91. PubMed ID: 19066415
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling: implications for cancer therapy.
    Skladanowski A; Bozko P; Sabisz M; Larsen AK
    Cell Cycle; 2007 Sep; 6(18):2268-75. PubMed ID: 17890906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.